3M4-34005-19433
3 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 928 / CA
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Dose 1 — Pfizer-BioNTech
-
2021-01-15
Registered in v-safe
- 2021-01-15
-
2021-01-20
Dose 2 — Pfizer-BioNTech
- 2021-01-27
-
2021-02-03
Survey response — day 14, dose 2MedDRA: Chills, Fatigue, Headache — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Fatigue, headache, chillsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-04-23
- 2021-07-21
-
2021-12-29
Dose 3 — Pfizer-BioNTech
- 2022-01-20
- 2022-01-21
- 2022-01-26
- 2022-02-02
- 2022-02-09
- 2022-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-20 | Pfizer-BioNTech | |
| 3 | 2021-12-29 | Pfizer-BioNTech | No |
Free text
Release 3 — day 14, dose 2
Symptoms: Fatigue, headache, chills
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release